—In an international study, a deep learning model, dubbed Deep-IO, showed a strong capability to predict clinical outcomes of immune checkpoint inhibitor therapy for patients with advanced non-small ...
Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell lung cancer (NSCLC) response to immune checkpoint inhibitors (ICIs), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results